Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-25 @ 4:46 PM
Study NCT ID:
NCT05888103
Status:
COMPLETED
Last Update Posted:
2025-04-20
First Post:
2023-05-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-24
First Submit QC Date:
None
Study First Post Date:
2023-06-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-01
Results First Submit QC Date:
None
Results First Post Date:
2025-04-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-01
Last Update Post Date:
2025-04-20
Last Update Post Date Type:
ACTUAL